Postoperative anemia is frequent in patients undergoing hip Background: and knee arthroplasty. While it is legitimate to think that anemia could decrease postoperative vigor and, consequently, limit the patient's rehabilitation, our previous study showed that anemia does not impair functional recovery in patients during the immediate postoperative period (10 days). Here we investigate the possible relationship between the postoperative hemoglobin (Hb) concentration and long-term (6 months or more) functional recovery and quality of life (QoL) in patients.
Introduction
Immediate postoperative anemia is common in patients who undergo a major hip or knee arthroplasty 1 . Consequently, clinicians have to decide whether or not a patient should receive a transfusion to counter postoperative anemia that may affect recovery. However, opinions are divided regarding the true need for, and benefit of, transfusions after major orthopedic surgeries. Several studies have suggested that the risk of postoperative morbidity is higher in patients with cardiovascular disease or those with a major illness and anemia after surgery 2, 3 . These results prompted physicians to adopt a more liberal transfusion strategy by regularly transfusing patients to hemoglobin (Hb) concentrations higher than 100 g/L 4 .
In contrast, a more conservative transfusion strategy is chosen by many clinicians, including those of the Centre Hospitalier de l'Université de Montréal (CHUM) 5 , due to the fact that patients are subject to frequent microcirculatory or immunosuppressive complications after a blood transfusion 4 . Furthermore, the risk of blood-transmitted pathogens (known and unknown) and the limited availability of blood products renders the liberal approach less attractive. A restrictive approach intended to limit transfusions only to patients with an Hb level lower than 70 g/L is, at the moment, favored considering these potential risks associated with blood transfusions 5 . An important randomized study including 838 intensive care patients showed that the use of a transfusion threshold of 70 g/L (with the aim of keeping the concentration of Hb between 70 and 90 g/L) was at least as safe as the use of a liberal strategy with a transfusion threshold of 100 g/L 4 . The 30 day postoperative death rate and the rates of cardiovascular complications and organ dysfunction were not significantly different with a restrictive strategy (and were even significantly lower in some subgroups), suggesting that patients who undergo surgery are able to tolerate Hb levels much lower than those previously admitted. According to these results, it seems that the use of a restrictive transfusion strategy does not affect mortality or morbidity in the immediate postoperative period (30 days after surgery). In addition, as described in the meta-analysis by Alvarez et al 2001, many studies have shown that the human body can adapt to lower [Hb] by increasing cardiac output and oxygen extraction along with a decrease in blood viscosity 6 . These adaptive changes could explain the similar results observed when using restrictive and liberal transfusion strategies.
The results of the recent Transfusion Requirements in Orthopedic Surgery (TRIOS) phase 2 trial also support a restrictive transfusion strategy 7 . They suggest, contrary to our initial hypothesis, that anemia does not affect functional recovery and quality of life (QoL) in patients immediately (1 to 10 days) after their surgery. Here we ask whether the lack of effects of anemia observed in our patients during the immediate postoperative period persists in the long-term period (6 months or more after surgery).
The objective of the present study was to establish the relationship between the postoperative Hb concentration, and functional recovery and QoL in the long-term after a major arthroplasty. Should there be a relationship between anemia and these two outcomes, we would be able to determine a minimal Hb level below which long-term functional recovery and QoL is affected. Should it exist, this threshold could help clinicians and patients decide between a liberal or a restrictive transfusion strategy after major orthopedic surgery.
We hypothesized that patients with a lower postoperative Hb concentration have a diminished functional recovery and QoL in the long-term after surgery, compared to those who have higher postoperative Hb concentration.
Materials and methods

Study design and population
We conducted a follow-up, observational study at the CHUMHôpital Notre-Dame to evaluate the long-term postoperative evolution of the 305 patients who participated in TRIOS phase 2 trial. The inclusion criteria of the initial TRIOS phase 2 trial were: being over the age of 60 at the time of surgery, candidacy for a knee or hip arthroplasty or a non-urgent prosthesis revision, the ability to walk prior to surgery and to provide informed consent to participate in the study. Additionally, an exclusion criterion implemented in this present follow-up study was that patients should not have had another surgery since the one for which they had been recruited originally. The protocol was evaluated and accepted by the ethics committee of the CHUM. Each patient was sent a letter inviting him/her to participate in the follow-up study by phoning one of the investigators (ACL). Verbal consent from each of the 160 patients who agreed to participate was obtained prior to completing the interview by telephone.
Primary outcomes
Functional recovery was measured with the Functional Status Index (FSI), a reliable and valid instrument allowing autoevaluation of physical function in adults 8 . This tool informs the clinician on three aspects of the physical function of the patient during a given activity. These three aspects include the need for assistance, the level of pain and the difficulty of performing a given activity. The sum of the results of these three aspects gives a global score describing how a patient perceives his or her physical condition. A high FSI score corresponds to a poor functional status 9 . Scores range from 54 for fully autonomous patients to 234 for patients experiencing a weak recovery.
Equally, the Short Form 36 (SF-36) was used to evaluate the QoL of patients 10 . This test provides a physical components score (PCS) and a mental components score (MCS) that evaluate these two functions. Scores range from 0-100, with higher scores indicating better health. On the physical components score, low scores indicate many limitations in physical activities; on the mental components score, low scores indicate problems with work or other daily activities as a result of emotional health 10 .
At the same time, patients were asked about complications or morbidities associated with postoperative anemia such as: cardiovascular, respiratory or neurological adverse events, major infections and non-specific symptoms of anemia (dizziness, weakness and fatigue). Hb concentrations were recorded on several occasions during the patient's stay at the hospital during the initial TRIOS phase 2 trial. We selected two of these recordings (taken during the preoperative medical consultation and after surgery, at the time of the 6 Minute Walk Test 11, 12 ) for each patient to establish correlations with long-term postoperative recovery.
Data collection
Each patient's file was consulted to obtain details on his/her general recovery, postoperative morbidities or mortality using surgery and physiotherapy notes. All this information was noted in a database.
For the evaluation of functional recovery and QoL using the FSI and the SF-36, each patient was asked to complete these questionnaires during a telephone interview. If a patient had not called back within 10 days after receiving the letter, a member of the team (ACL) called the patient to obtain his/her consent to participate in the study.
During the phone call to the patient, a member of the team (ACL) would read every question and note the patient's answers. Data for FSI, SF-36 and postoperative complications were all obtained during the same phone call. Time from the original TRIOS phase 2 trial to follow-up ranged between 6 months to 3 years. Twenty six to 36 patients completed the questionnaire each week during 7 consecutive weeks, making a total of 160 respondents.
SF-36 scores (PCS and MCS) were calculated using QualityMetric Inc. SF Health Outcomes TM Scoring Software (Lincoln, RI http://www.qualitymetric.com).
Statistical analysis
Data were analyzed in order to determine a Hb concentration below which functional recovery and QoL in patients are impaired. Relationships between Hb concentrations and FSI or SF-36 scores were studied by linear regression using two main models. The first investigated scores in association with postoperative Hb concentration and the second investigated scores in association with individual changes between the preoperative and postoperative [Hb] recordings. An eventual non-linear effect of postoperative Hb on FSI scores was also verified. A p value < 0.05 was considered statistically significant. All analyses were completed using LaTeX and R version 2.13.0 software by the CHUM's statistician (MPS).
Results
From February to March 2011, the 305 patients who participated in the TRIOS phase 2 were asked to contact a member of the research team (ACL) to complete FSI and SF-36 questionnaires. Among those 305 patients, 184 were available and accepted to take part in the study at the moment of the phone call but 24 of them were excluded because they had had another surgery since their original operation. As a result, the information of 160 patients was considered. Table 1 presents the main demographic characteristics of the 160 patients who participated in the follow-up study. The average age of the patients was 72.4 years (range 60-91) and 64% of them were women. The average patient's body mass index (BMI) was 30.5 kg/m 2 (range 16.2-51.5) and the average (range 1-3) American Society of Anesthesiologists' (ASA) physical status score was 2 (patients with a systemic pathology that does not limit his/her activities) in the majority of patients (61.3%). Eighty-two patients underwent a total knee arthroplasty (TKA) and 78 underwent a total hip arthroplasty (THA). Table 2 shows average preoperative and postoperative (1 to 10 days after surgery -average 4.6 days) Hb concentrations, average FSI and SF-36 scores and the number of patients who had major complications after surgery. There was a 36.2 g/L events of any type (cardiovascular, respiratory or neurological adverse events, major infections and non-specific symptoms of anemia -dizziness, weakness and fatigue) was low, ranging between 1.9 to 8.1%. Figure 1 .
As shown in Figure 1 , there was no statistically significant association between postoperative [Hb] and FSI, PCS or MCS scores. The distribution of the dots in Figure 2 reflects a similar lack of association between Hb concentration and postoperative complications (marked by filled circles). The percentage of patients who had adverse completion of the follow-up questionnaire on patients' scores was considered. Time was not statistically associated with PCS and MCS scores but it was statistically correlated with FSI scores (FSI scores worsened as time elapsed; p = 0.0108). 
Discussion
Contrary to our preliminary hypothesis, we were unable to find a relationship between the immediate postoperative Hb concentration (or the difference between pre and postoperative Hb) and functional recovery or QoL in patients in the long-term period after a major arthroplasty. Also, there were no significant correlations between postoperative Hb levels and adverse events or morbidities thought to be associated with postoperative anemia. Consequently, we could not establish a Hb threshold below which functional recovery and QoL in patients are affected. The SF-36 and FSI data were analyzed by linear regression using two main models (one studied scores in association with postoperative Hb and the second investigated scores in association with individual differences between pre and postoperative Hb concentrations). There were no significant associations of these two models with SF-36 and FSI. We also considered an eventual non-linear effect of postoperative Hb on FSI scores to ensure that all correlation models were investigated. Again, there were no associations between postoperative Hb and FSI scores.
Two recent studies support the lack of effects of postoperative anemia on functional recovery and QoL in patients undergoing a major arthroplasty. A randomized clinical trial involving 2016 patients at high cardiovascular risk demonstrated that a liberal transfusion strategy, as compared with a restrictive strategy, did not reduce the death rates, the ability to walk independently or the rates of in-hospital morbidities 60 days after hip-fracture surgery 13 . Moreover, the results of the TRIOS phase 2 trial also showed that moderate anemia does not affect functional recovery or QoL in patients during the immediate postoperative . Considering these outcomes and the fact that recovery from anemia is relatively rapid 7 , it is not entirely surprising that the long-term effects of anemia on functional recovery and QoL were minimal in the present study (Tables 3 and 4) .
On the other hand, a recent literature review by Spahn suggests that an increase in postoperative mortality and morbidity could be associated with perioperative anemia 1 . This review concluded that perioperative anemia is associated with postoperative infections, poorer physical functioning and recovery, and increased length of hospital stay and mortality 1 . However, prospective clinical studies are required to validate these conclusions. In contrast to Spahn's review, results of the FOCUS trial demonstrated that the frequency of in-hospital morbidities (including pneumonia, wound infection, thromboembolism, stroke or transient ischemic attack and clinically recognized myocardial infarction), the inability to walk independently on a 60-day follow-up, length of hospital stay and mortality rates were not reduced by using a liberal transfusion strategy (maintaining [Hb] over 100 g/L) as compared with a restrictive strategy (transfusion for symptoms of anemia or at physician discretion for a [Hb] below 80 g/L) 13 .
Several studies have investigated the relationship between postoperative anemia and functional outcomes in patients after surgery. As reviewed in the study by Vuille-Lessard et al, the conclusions of these studies tend to diverge, but in general, most evidence-based studies indicated that the effects of anemia on functional recovery and QoL are limited 7 .
A major strength of the present study is that we used two different questionnaires to evaluate the patients' physical and psychological function. This enhances the validity of the results. Another strength of the study is the reliability and validity of the instruments used to collect data. Functional recovery was measured using the FSI, a valid and reliable instrument allowing auto-evaluation of physical function in adults 8 ,while QoL was evaluated using the well-validated SF-36 10 .
Weaknesses of this study include the inability or the refusal of some patients to report a representative description of their physical and psychological condition. Furthermore, some interviewed patients had concurrent health problems (cancer, diabetes, renal insufficiency and arthritis for example) in addition to their orthopedic surgery that might have also affected their FSI or SF-36 scores. As a result, some patients recovering well from either THA or TKA may have presented low physical function scores due to other health problems. However, this possibility would have affected our results negatively, which was not the case since, overall, FSI scores indicated a good functional recovery. Another weakness of this study is its follow-up observational design and the variable time between surgery and follow-up. Given that total recovery from THA or TKA is relatively rapid 7 , the difference in time between surgery and the follow-up questionnaire (3 months to 6 years) may have affected the scores to the questionnaires relating to the patient's recovery and. yet, our results show that this was not the case for PCS and MCS scores and FSI scores were negatively affected by a longer time interval between surgery and the follow-up questionnaire.
In summary, postoperative anemia does not appear to affect long-term (6 months or more) functional recovery and QoL in patients undergoing THA or TKA. Our follow-up results confirm the lack of effects of anemia on functional recovery and QoL during the immediate postoperative period observed in the TRIOS phase 2 study.
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